Clinical Study

Correlation of High-Risk Soft Tissue Sarcoma Biomarker Expression Patterns with Outcome following Neoadjuvant Chemoradiation

Table 1

Changes in tumor biomarker expression following neoadjuvant chemoradiation in 12 “matched pair” large, deep, high-risk soft tissue sarcoma patients.

MarkerPretreatment valuePosttreatment value value
MeanSDMeanSD

ACIS Ki67
 Percentage15.9119.787.657.300.0674
p53
 Nuclear/cytoplasmic ratio1.440.221.900.740.0469
ATM
 Nuclear8349.361920.357870.752114.360.4961
 Cytoplasm3811.692121.293116.211035.730.4258
 Tumor mask5289.392400.714412.801205.370.3594
PARP1
 Nuclear7042.801361.765533.591198.180.0313
 Cytoplasm3281.97798.552293.63471.640.0938
 Tumor mask4354.821092.113263.65674.800.0625
ERCC1
 Nuclear9433.462247.208586.981658.740.3594
 Cytoplasm3046.291563.802197.19917.540.0977
 Tumor mask5150.351600.284206.671335.080.0977
XPF
 Nuclear8772.271076.088880.112407.450.8457
 Cytoplasm4694.751556.584240.831254.750.3750
 Tumor mask6004.001598.715511.371619.800.4316
CAIX
 Nuclear3939.811273.122406.95977.100.0234
 Cytoplasm3931.011699.382037.18944.150.0391
 Tumor mask3972.931569.582124.05926.910.0156
GLUT1
 Nuclear5389.902886.982937.341198.240.0781
 Cytoplasm4932.263106.792496.811116.730.1094
 Tumor mask5054.192998.352658.881128.220.0469
HIF-1α
 Nuclear6267.081603.955787.912241.580.4609
 Cytoplasm3857.751221.782978.521433.300.1484
 Tumor mask4582.471435.494009.572108.140.3828

SD: standard deviation; values are from the Wilcoxon signed-rank test on log-transformed values.